Keyphrases
Protective Mechanism
100%
Ebola Virus
100%
Trivalent
100%
Antibody-mediated
100%
Parainfluenza Virus
100%
Zaire
37%
Antibody Response
25%
Guinea pig
25%
Monovalent Vaccine
25%
Mucin-like Domain
25%
Polyvalent Vaccine
25%
Survivors
12%
Immunization
12%
Vaccine Immunization
12%
Multiple Approaches
12%
Sudan
12%
Human Disease
12%
Glycoprotein
12%
Monoclonal Antibody
12%
Case Fatality Rate
12%
Epitope
12%
Amino Acids
12%
Broad Protection
12%
Envelope Glycoprotein
12%
Mucosal Response
12%
Respiratory Tract
12%
Trivalent Vaccine
12%
Monovalent Cations
12%
Comparative Analysis
12%
Neutralizing Antibodies
12%
Bovine Parainfluenza Virus Type 3 (BPIV3)
12%
Ebola Virus Infection
12%
Glycan Cap
12%
Linear Epitope
12%
Vectored Vaccine
12%
Bundibugyo
12%
Immune Serum
12%
Consensus-based
12%
Protective Antibodies
12%
Antibody Repertoire
12%
Single Virus
12%
Competitive Binding Assay
12%
Peptide Microarray
12%
Needle-free
12%
Membrane Proximal External Region
12%
Neutralizing Responses
12%
Glycoprotein Glycans
12%
Antibody Fc
12%
Immunology and Microbiology
Ebola Virus
100%
Paramyxovirinae
100%
Glycoprotein
50%
Zaire Ebolavirus
50%
Antibody Response
33%
Guinea Pig
33%
Mucin
33%
Monoclonal Antibody
16%
Epitope
16%
Case Fatality Rate
16%
Neutralizing Antibody
16%
Triple Vaccine
16%
Antiserum
16%
Parainfluenza Virus
16%
Human Parainfluenza Virus 3
16%
Glycan
16%
Linear Epitope
16%
Binding Competition
16%
Peptide Microarray
16%
Virus
16%
Amino Acid
16%
Infection
16%